Onconetix, Inc. (ONCO)

USD 0.38

(-18.72%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 58.46 Thousand - - - -
Cost of Revenue 1.18 Million 6752.00 4890.00 3056.00 573.00
Gross Profit -1.12 Million -6752.00 -4890.00 -3056.00 -573.00
Operating Expenses 34.9 Million 13.48 Million 3.41 Million 1.62 Million 879.65 Thousand
Selling, General and Administrative Expenses 14.77 Million 9.35 Million 2.09 Million 1.09 Million 819.48 Thousand
Research and Development Expenses 1.94 Million 4.12 Million 1.32 Million 524.9 Thousand 60.17 Thousand
Other Expenses 18.18 Million - - - -
Cost and Expenses 36.09 Million 13.48 Million 3.41 Million 1.62 Million 880.23 Thousand
Operating Income -36.03 Million -13.48 Million -3.41 Million -1.62 Million -880.23 Thousand
Interest Expense 671.62 Thousand - - - -
Income Tax Expense -12.59 Thousand -61.41 Thousand -4.00 -203.24 Thousand -3.00
Earnings before Tax -37.42 Million -13.41 Million -3.41 Million -1.59 Million -821.91 Thousand
Net Income -37.4 Million -13.41 Million -3.41 Million -1.59 Million -821.91 Thousand
Earnings Per Share Basic -2.19 -1.09 -0.31 -0.14 -0.07
Earnings Per Share Diluted -2.19 -1.09 -0.31 -0.14 -0.07
Weighted Average Shares Outstanding 17.11 Million 12.27 Million 10.91 Million 11.04 Million 11.04 Million
Weighted Average Shares Outstanding (Diluted) 17.11 Million 12.27 Million 10.91 Million 11.04 Million 11.04 Million
Gross Margin -19.28 - - - -
EBIT Margin -627.84 - - - -
Profit Margin -639.86 - - - -
EBITDA -36.7 Million -13.53 Million -3.41 Million -1.61 Million -821.34 Thousand
Earnings Before Tax Margin -616.34 - - - -

Income Statement Charts